Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The U.S. government's Biomedical Advanced Research and Development Authority (BARDA) selected opaganib for joint development & funding as a medical countermeasure (MCM) to treat Ebola virus disease ...

According to Future Market Insights (FMI), the United States green tea supplement market value is set to reach USD 177.9 ...

Data show more patients treated with mirikizumab achieved histologic response at Week 52 compared to ustekinumab INDIANAPOLIS, Oct. /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced data ...

Researchers have unveiled a novel approach to tackle obesity by targeting fat absorption in the small intestine. The ...

In a report released on October 10, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on Novo Nordisk (0QIU – Research ...

Astonishing findings from the German Rheumatism Congress in Düsseldorf: poor dental hygiene increases the risk of developing ...